-
Views
-
Cite
Cite
Ann M Gronowski, Shannon Haymond, Basil Harris, Chung Kang Peng, Sandeep (Sonny) S Kohli, A Q&A with the Qualcomm Tricorder XPRIZE Winners, Clinical Chemistry, Volume 64, Issue 4, 1 April 2018, Pages 631–635, https://doi.org/10.1373/clinchem.2017.278853
Close - Share Icon Share
Extract
In recent years, there has been an increasing demand for “health consumer technologies”—small, user-friendly, point-of-care devices that can be operated by untrained individuals to evaluate health and disease. The Qualcomm Tricorder XPRIZE was a $10 million global competition to stimulate innovation and integration of advanced technologies, enabling reliable health diagnoses anywhere and anytime (https://tricorder.xprize.org/). The competition called for the development of a device that could diagnose 12 diseases (and the absence of disease) and capture 5 real-time health vital signs independent of a healthcare professional or facility. Devices also could not weigh >5 pounds and required the capability to transmit data to a cloud storage and computing system. Although diagnostic accuracy was a key component, the competition was unique in its strong emphasis on user adoption and experience. In fact, only teams scoring the highest on the consumer experience evaluations were eligible to win the overall competition.
After the competition's launch in 2012, >300 teams joined. In April 2017, 3 winners were announced. Final Frontier Medical Devices, led by Basil Harris, was announced the highest performing team and received $2.6 million for their achievement. Dynamical Biomarkers Group, led by Chung Kang Peng, received $1 million for second place. Cloud DX, led by Sonny Kohli, was also recognized as XPRIZE's first Bold Epic Innovator and received $100000.
